Countdown to 2022 CBIIC:

LI Wenbin

Vice-Chairman & Secretary-General of PhIRDA Clinical Research on Cranial Nerve Drugs Specialty Committee Director of Cancer Center, Beijing Tiantan Hospital, Capital Medical University

Wenbin Li, Chief physician, Professor, Doctoral supervisor, Director of Cancer Center of Beijing Tiantan Hospital affiliated to Capital Medical University, Assistant to the Dean of National Institute of Health Data Science at Capital Medical University, Director of Department of Clinical Oncology at Capital Medical University, Vice chairman of Clinical Research on Cranial Nerve Drugs Specialty Committee of China Pharmaceutical Innovation and Research Development Association, Standing Committee of Society for Neuro-Oncology of China, Director of Department of Journal and Publishing of China Anti-Cancer Association, Vice chairman of the Society of Neuro-Oncology of China Anti-Cancer Association, Editorial board member of《Signal Transduction and Targeted Therapy》and《Cancer Biology & Medical》, Editor-in-chief of 《China Health Standard Management》, Chief editor of 《Medical Reference》, Leading Talent of Beijing Traditional Chinese and Western Medicine, The famous doctor of China--Excellent demeanor in 2020, Honorary Research Fellow of University of South Florida of America. He was dedicated to chemotherapy for malignant tumors and clinical trial for drugs, and leaded 2 first-in-class drugs clinical trials of National Science and Technology Major Project. China General coordinator for international multicenter clinical trial-GBM AGILE